Merck KGaA (OTCMKTS:MKKGY) Reaches New 52-Week Low – Here’s Why

Merck KGaA (OTCMKTS:MKKGY)’s share price hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $23.7330 and last traded at $23.92, with a volume of 248899 shares changing hands. The stock had previously closed at $23.90.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on MKKGY shares. Deutsche Bank Aktiengesellschaft cut shares of Merck KGaA from a “buy” rating to a “hold” rating in a research report on Tuesday, February 3rd. Sanford C. Bernstein raised shares of Merck KGaA to a “hold” rating in a research note on Thursday, March 19th. Four research analysts have rated the stock with a Hold rating, According to MarketBeat, Merck KGaA presently has a consensus rating of “Hold”.

Merck KGaA Trading Up 0.1%

The company has a debt-to-equity ratio of 0.36, a current ratio of 1.49 and a quick ratio of 0.97. The company has a market cap of $15.46 billion, a price-to-earnings ratio of 10.63, a price-to-earnings-growth ratio of 2.13 and a beta of 0.96. The business’s fifty day moving average price is $28.51 and its 200 day moving average price is $27.59.

Merck KGaA (OTCMKTS:MKKGY) last posted its quarterly earnings data on Thursday, March 5th. The company reported $0.28 earnings per share for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.19). The company had revenue of $6.11 billion during the quarter, compared to analyst estimates of $6.20 billion. Merck KGaA had a net margin of 12.31% and a return on equity of 9.02%. Research analysts anticipate that Merck KGaA will post 1.87 earnings per share for the current fiscal year.

About Merck KGaA

Merck KGaA, Darmstadt, Germany, commonly referred to as Merck Group, is a multinational science and technology company with origins dating back to 1668. The company develops and manufactures products and technologies across healthcare, life science and electronics applications. It is distinct from the U.S. pharmaceutical company Merck & Co; Merck KGaA is a European group headquartered in Darmstadt and is publicly listed in Germany with an OTC American depositary receipt available under the symbol MKKGY.

Merck’s Healthcare business develops prescription medicines and related services focused on areas such as oncology, immunology, neurology (including therapies for multiple sclerosis) and fertility.